Ghana vs Korea: The number of people with susceptibility test result for rifampicin
Ghana
8,532
in 2021
Korea
9,284
in 2021
Ghana rank
24th
Korea rank
22nd
The number of people with susceptibility test result for rifampicin over time
- Ghana
- Korea
How they compare
Korea currently reports 9,284 against 8,532 in Ghana, a difference of 752.
That makes Korea's figure about 1.1 times Ghana's.
Across all 5 years both countries report, Korea has been ahead every year.
Ghana ranks 24th and Korea ranks 22nd of 155 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ghana | Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8,062 | 13,475 | 5,413 | Korea |
| 2020s | 8,274 | 9,936 | 1,662 | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Ghana or Korea?
- Korea, at 9,284 against 8,532 in Ghana as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Ghana and Korea?
- 752, with Korea ahead.
- How many years of comparable data are there for Ghana and Korea?
- 5 years are reported by both, from 2017 to 2021.
- How do Ghana and Korea rank globally for the number of people with susceptibility test result for rifampicin?
- Ghana ranks 24th and Korea ranks 22nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.